C4 Therapeutics, Inc. Liquidation Value
CCCC
Other
Cash & Equivalents
$74.60M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $74.60M
Total Obligations: -$93.01M
$-18.41M
Per share: $-0.19
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $74.60M
AR: $2.40M
Total Obligations: -$93.01M
$-16.01M
Per share: $-0.17
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $74.60M
AR: $2.40M
Inventory: $0
Total Obligations: -$93.01M
$-16.01M
Per share: $-0.17
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-18.41M | $-0.19 |
| Liquid Liquidation Value | $-16.01M | $-0.17 |
| Operating Liquidation Value | $-16.01M | $-0.17 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $74.60M |
| Accounts Receivable | $2.40M |
| Inventory | N/A |
| Current Liabilities | $33.03M |
| Long-term Debt | N/A |
| Op. Lease Liability | $59.98M |
| Finance Lease | N/A |
| Shares Outstanding | 96.9M |
Explore all 175 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $74.60M | $2.40M | N/A | $858,000 | $33.03M | N/A | $59.98M | N/A |
| 2025-09-30 | $58.81M | $6.54M | N/A | $1.33M | $35.95M | N/A | $61.46M | N/A |
| 2025-06-30 | $78.16M | $2.16M | N/A | $2.22M | $44.46M | N/A | $62.92M | N/A |
| 2025-03-31 | $51.29M | $8.03M | N/A | $683,000 | $40.82M | N/A | $64.37M | N/A |
| 2024-12-31 | $55.50M | $3.10M | N/A | $1.33M | $45.18M | N/A | $65.76M | N/A |
| 2024-09-30 | $59.65M | $10.34M | N/A | $1.50M | $43.29M | N/A | $67.09M | N/A |
| 2024-06-30 | $73.11M | $1.17M | N/A | $913,000 | $54.20M | N/A | $68.42M | N/A |
| 2024-03-31 | $89.66M | $13.60M | N/A | $1.63M | $55.02M | N/A | $69.72M | N/A |
▼ Community Notes